跳至主要内容
临床试验/NCT02160249
NCT02160249已完成不适用

RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia): a Cluster-randomised Trial

London School of Hygiene and Tropical Medicine1 个研究点 分布在 1 个国家目标入组 166 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
166
试验地点
1
主要终点
Disability (36-item WHODAS (World Health Organisation Disability Assessment Schedule) 2.0)

研究概览

简要总结

The purpose of this study is to determine whether community-based rehabilitation plus facility-based care is superior to facility-based care alone in reducing disability related to schizophrenia in rural Ethiopia.

详细描述

This is a cluster randomised trial set in rural Ethiopia with kebeles (villages) as the unit of randomisation. 54 kebeles will be included. 27 will be randomly allocated to the intervention arm (Facility based care (FBC) + Community-based Rehabilitation (CBR)) and 27 randomly allocated to the control arm (FBC alone).

The aim is to determine whether CBR + FBC is superior to FBC alone in reducing disability related to schizophrenia, measured by the WHO Disability Assessment Schedule version 2.0 (WHODAS 2.0) at 6 and 12 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years
  • Diagnosis of schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using (DSM-IV) criteria
  • Evidence of severe, enduring or disabling illness
  • Resident in kebele for >6 months and no immediate plans to leave the kebele
  • Has a primary caregiver who is willing to participate in the study

排除标准

  • No specific criteria

结局指标

主要结局

Disability (36-item WHODAS (World Health Organisation Disability Assessment Schedule) 2.0)

时间窗: 12 months

次要结局

  • Disability (36-item WHODAS 2.0)(6 months)
  • Functioning (indigenous functioning scale)(6 and 12 months)
  • Medication adherence (4 item Morisky Medication Adherence Scale)(6 and 12 months)
  • Serious adverse events(6 and 12 months)
  • Economic activity of caregiver(6 and 12 months)
  • Caregiver depression (PHQ9 +1)(6 and 12 months)
  • Economic activity of patient (employment, income and household work)(6 and 12 months)
  • Symptom severity (Brief Psychiatric Rating Scale- Expanded version (BPRS-E))(6 and 12 months)
  • Clinical Global Impression (CGI)(6 and 12 months)
  • Relapse (Longitudinal Interval Follow up Evaluation: DSM-IV version (LIFE))(6 and 12 months)
  • Proportion with human rights problems (chaining or restraint)- Caregiver-reported(6 and 12 months)
  • Engagement with facility based care(6 and 12 months)
  • Caregiver burden (WHO Family Interview Schedule Impact section)(6 and 12 months)
  • Patient medication adherence(6 and 12 months)
  • Proportion with human rights problems (chaining or restraint)- self-reported(6 and 12 months)
  • Nutritional status (BMI)(6 and 12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验